Concomitant medical products: product id: 3889-28, lot #: (b)(4), implanted: (b)(6) 2018, explanted: (b)(6) 2018, product type: lead.Product id: 3889-28, lot #: (b)(4), implanted: (b)(6) 2018, explanted: (b)(6) 2018, product type: lead.Product id: 355018, lot #: (b)(4), product type: accessory.Other relevant device(s) are: product id: 3889-28, serial/lot #: (b)(4), ubd: 01-aug-2022, udi#: (b)(4).Product id: 3889-28, serial/lot #: (b)(4), ubd: 01-aug-2022, udi#: (b)(4).Product id: 355018, serial/lot #: (b)(4), ubd: 06-oct-2019, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
Information was received from the health care provider via the manufacturer representative reporting that five weeks after the leads were implanted, the implantable neurostimulator (ins) was intended to be implanted.When opening the pocket where the lead was connected to the extension, it was observed that the pocket was purulent.There were no external contributing factors.The patient was examined.The action taken was the leads were explanted and the patient was treated with antibiotics.The health care provider analyzed the lead in bacteriology.The following results were found: smear test of wound performed intraoperatively revealed moderate amount of gram-positive cocci, moderate amount of leucocytes, cell detritus in aerob.Cultures.Depending on the smear test, there was suspected staphylococci or staphylococcus aureus.It was noted that other surgeries done at the same time as this event were being checked if they were affected by potential contamination.The issue was note resolved.The patient was alive with no injury.No further complications were reported.
|